On January 13, 2026, Ferocity Capital hosted its inaugural Biodefense Summit in San Francisco, bringing together leaders from government, industry, and the investment community to discuss the future of innovation in biodefense.

The event featured a keynote from Dr. Michael Koeris, Director of DARPA BTO, and a panel of DARPA program managers moderated by Dr. Taryn Rose. Conversations focused on early-stage funding, strategic partnerships, regulatory considerations, and breakthrough technologies.

The summit highlights Ferocity’s role in advancing the biodefense ecosystem and its unique position at the intersection of national security and commercial opportunity.